Acute Myeloid Leukemia Clinical Trial
A Long-term Follow-up Study of Patients Who Received VOR33
Summary
VOR33 long-term follow-up (LTFU) study
Full Description
VBP201 study is the VOR33 long-term follow-up (LTFU) study focusing on assessing long term safety and efficacy of VOR33. This study may last up to 15 years (counted from the date of VOR33 infusion completion). All patients who have participated in a study involving the drug product VOR33 and have completed the applicable study or prematurely discontinued, but have at least received the VOR33 infusion, will be asked to participate in the LTFU study.
Eligibility Criteria
Inclusion Criteria:
A patient is included in this study if he/she:
Has received any part of or all of a VOR33 infusion
Exclusion Criteria:
There are no exclusion criteria.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 9 Locations for this study
La Jolla California, 92037, United States More Info
Principal Investigator
Miami Florida, 33176, United States More Info
Principal Investigator
Saint Louis Missouri, 63110, United States More Info
Principal Investigator
Hackensack New Jersey, 07601, United States More Info
Principal Investigator
New York New York, 10032, United States More Info
Principal Investigator
New York New York, 10065, United States More Info
Principal Investigator
Cleveland Ohio, 44106, United States More Info
Principal Investigator
Seattle Washington, 98109, United States More Info
Principal Investigator
Montréal Quebec, H1T 2, Canada More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.